![](/img/cover-not-exists.png)
AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer
Antoniotti, Carlotta, Borelli, Beatrice, Rossini, Daniele, Pietrantonio, Filippo, Morano, Federica, Salvatore, Lisa, Lonardi, Sara, Marmorino, Federica, Tamberi, Stefano, Corallo, Salvatore, Tortora,Volume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07169-6
Date:
December, 2020
File:
PDF, 772 KB
2020